Gore & Associates G.K. in Minato-ku, Tokyo, Japan, announced the first clinical use in Japan of the Gore Excluder thoracoa ...
IceCure Medical Ltd. announced that four abstracts featuring data from independent clinical studies conducted in Spain and ...
Penumbra announced the publication of a new study that showed that the use of the company’s computer-assisted vacuum thr ...
Johnson & Johnson MedTech announced that the FDA has approved an expanded indication for the company’s TruFill n-But ...
Medtronic announced that results from the company-sponsored In.Pact Admiral drug-coated balloon (DCB) French Quality of Life ( ...
Gore & Associates announced the first implantation of its investigational Gore Ascending Stent Graft in the ARISE III tria ...
Teleflex Incorporated announced it has entered into definitive agreements to sell the company’s acute care, interventiona ...
Biocoat, Inc. announced the formation of Surmodics Services & Technologies, a newly named division of Surmodics, Inc. that ...
The purpose of this commentary is to critically examine the CREST-2 results, discuss their implications for clinical decision-making for asymptomatic carotid artery disease, and guide clinicians ...
Bendit Technologies, an Israel-based developer of a steerable microcatheter platform, announced that the FDA has granted ...
Medtronic announced the first commercial use of the Liberant thrombectomy system, which is indicated for the removal of fresh, ...
December 11, 2025—Medtronic announced that the Onyx liquid embolic system (LES)—Onyx 18 and Onyx 34—is now indicated in the United States for embolization of the middle meningeal artery (MMA) as an ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results